Weaver Consulting Group Brainstorm Cell Therapeutics Inc. Call Options Transaction History

Weaver Consulting Group

6 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2023 Jan 22, 2024	SELL	$0.15 - $0.4 $5,250 - $14,000	-35,000 Reduced 77.78%	10,000 $2,000
Q3 2023 Oct 13, 2023	SELL	$0.2 - $2.08 $1,180 - $12,272	-5,900 Reduced 11.59%	45,000 $9,000
Q2 2023 Jul 19, 2023	BUY	$2.0 - $3.2 $42,000 - $67,200	21,000 Added 70.23%	50,900 $104,000
Q1 2023 Apr 11, 2023	SELL	$1.43 - $3.3 $33,748 - $77,880	-23,600 Reduced 44.11%	29,900 $98,000
Q4 2022 Jan 09, 2023	SELL	$1.37 - $3.39 $22,605 - $55,935	-16,500 Reduced 23.57%	53,500 $0

Q3 2022 Oct 04, 2022	BUY	$2.55 - $4.3 $178,500 - $301,000	70,000 New	70,000 $20,000

4.09M

63.2K

800

Ticker BCLI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 36,486,200
Market Cap $12.4M
Description
Brainstorm Cell Therapeutics Inc., a biotechnology company, engages in the development and commercialization of autologous cellular therapies for the treatment of neurodegenerative diseases. The company, through its NurOwn proprietary cell therapy platform, leverages cell culture methods to induce autologous bone marrow-derived mesenchymal stem ...

Get notified when there are updates to the investment portfolio of Weaver Consulting Group, based on Form 13F filings with the SEC.

Stay updated on Weaver Consulting Group with notifications on news.